Standout Papers
Citation Impact
Citing Papers
Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society
1997
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Right Ventricular Function and Failure
2006
Sleep in the intensive care unit
2004
Quantitative Aspiration During Sleep in Normal Subjects
1997
Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
1996
Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes
2007
Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
2006
Outcome of Pulmonary Vascular Disease in Pregnancy: A Systematic Overview From 1978 Through 1996
1998
Primary Pulmonary Hypertension
2000
Dynamic T-Cell Changes in Peripheral Blood and Bronchoalveolar Lavage after Antigen Bronchoprovocation in Asthmatics
1991
Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension
2003
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
2003
Auditory and non-auditory effects of noise on health
2013 Standout
Medical Therapy For Pulmonary Arterial Hypertension
2004
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension
1998
Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension
1999
Role of Serial Quantitative Assessment of Right Ventricular Function by Strain in Pulmonary Arterial Hypertension
2012
Is long-term functional outcome after lung volume reduction surgery predictable?✩
2000
Perfusion Scan Findings Understate the Severity of Angiographic and Hemodynamic Compromise in Chronic Thromboembolic Pulmonary Hypertension
1988
SYSTEMIC FAT EMBOLISM AND PULMONARY HYPERTENSION IN SICKLE CELL DISEASE
1996
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia
2001
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Exercise induced bronchoconstriction in adults: evidence based diagnosis and management
2016
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Chronobiological Studies on the Nucleolus
1985
Surgical Treatments/Interventions for Pulmonary Arterial Hypertension
2004
Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial
2008 Standout
Sleep in Acute Care Settings: An Integrative Review
2000
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
2006
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Clinical efficacy of sildenafil in primary pulmonary hypertension
2004
Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension
2008
Rare diseases bullet 5: Primary pulmonary hypertension
1999
A USA-based registry for pulmonary arterial hypertension: 1982–2006
2007
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
2003 Standout
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension
2004
Primary pulmonary hypertension: Current therapy
2002
Chronic thromboembolic pulmonary hypertension
2018
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy
2003
Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: An observational study
2011
Survival with first-line bosentan in patients with primary pulmonary hypertension
2005
Exercise Testing Revisited
1994
Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion
1997
Primary pulmonary hypertension
1988
The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension
1989
Incidence of Pulmonary Hypertension and Its Clinical Relevance in Patients With Sarcoidosis
2006
Primary Pulmonary Hypertension
1997 Standout
Pulmonary Arterial Hypertension
2006
Single Lung Transplantation for Primary Pulmonary Hypertension
1990
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
SURGICAL OPTIONS FOR PATIENTS WITH ADVANCED EMPHYSEMA
1997
Creation of a Model Comparing 6-Minute Walk Test to Metabolic Equivalent in Evaluating Treatment Effects in Pulmonary Arterial Hypertension
2007
Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension
1999
Primary pulmonary hypertension
2003
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
2006
Surgical and Interventional Therapies for Pulmonary Arterial Hypertension
2005
Asthma
2017 Standout
Chronic thromboembolic pulmonary hypertension
2004
Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension
2005
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
The Short-term Effects of Digoxin in Patients With Right Ventricular Dysfunction From Pulmonary Hypertension
1998
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels
1995
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease
2016
Descriptive patterns of severe chronic pulmonary hypertension by chest radiography
2004
Clinical Exercise Testing
2001
Diagnosis and differential assessment of pulmonary arterial hypertension
2004
The Current Treatment of Pulmonary Arterial Hypertension
2006
Diagnosis and Assessment of Pulmonary Arterial Hypertension
2009
Ultrasonicversusjet nebulization of iloprost in severe pulmonary hypertension
2001
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
2001
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
2001 Standout
Risk factors for chronic thromboembolic pulmonary hypertension
2008
Comparison of Peak Expiratory Flow Rate and FEV1 in Assessing Bronchomotor Tone after Challenges with Occupational Sensitizers
1991
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
Bosentan Therapy for Pulmonary Arterial Hypertension
2002 Standout
Tadalafil: A Long-Acting Phosphodiesterase-5 Inhibitor for the Treatment of Pulmonary Arterial Hypertension
2011
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Sickle-cell disease
2010 Standout
The Metabolic Basis of Pulmonary Arterial Hypertension
2014
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
2002
Characteristics and Outcomes of Patients With Sarcoidosis Listed for Lung Transplantation
2001
Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation
2008
Ventilation-Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary Hypertension
2007
Assessing right ventricular function: the role of echocardiography and complementary technologies
2006
International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
2006
Systemic sclerosis-associated pulmonary hypertension: Short- and long-term effects of epoprostenol (prostacyclin)
1999
Idiopathic Pulmonary Fibrosis
2001 Standout
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
2014 Nobel
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
2003
Chronic Thromboembolic Pulmonary Hypertension
2001
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
1993 Standout
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension
2007
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
2005
Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension.
1995
Prognosis of Pulmonary Arterial Hypertension*
2004
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
2002
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
2005
Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension
2000
Value of a Doppler-Derived Index Combining Systolic and Diastolic Time Intervals in Predicting Outcome in Primary Pulmonary Hypertension
1998
Congestive Heart Failure and Central Sleep Apnea
2016
Lung and heart-lung transplant practice patterns in pulmonary hypertension centers
2001
Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene
2000
Idiopathic pulmonary fibrosis
2011 Standout
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
1999
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Sarcoidosis
2007 Standout
Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome
2002
Right and Left Ventricular Dysfunction in Patients With Severe Pulmonary Disease
1998
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
2006
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial
2002
Comparison Between Peak Expiratory Flow Rates (PEFR) and FEV1 in the Monitoring of Asthmatic Subjects at an Outpatient Clinic
1994
Pulmonary endarterectomy
2000
Chronic thromboembolic pulmonary hypertension
2014
Right Ventricular Pressure Waveform and Wave Reflection Analysis in Patients With Pulmonary Arterial Hypertension
2007
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
2012
Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids
2003
Introduction
2004
Physiologic Measures: Pulmonary Function Tests
1994
Determination of Cardiac Output by the Fick Method, Thermodilution, and Acetylene Rebreathing in Pulmonary Hypertension
1999
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension
2000
Outcome in 91 Consecutive Patients with Pulmonary Arterial Hypertension Receiving Epoprostenol
2003
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension
2002 Standout
An Official American Thoracic Society Clinical Practice Guideline: Exercise-induced Bronchoconstriction
2013
Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension
2004
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Pulmonary Arterial Hypertension in France
2006 Standout
Serum Uric Acid Levels Correlate with the Severity and the Mortality of Primary Pulmonary Hypertension
1999
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Chronic major-vessel thromboembolic pulmonary hypertension.
1990
Prognostic Value of Right Ventricular Longitudinal Peak Systolic Strain in Patients With Pulmonary Hypertension
2012
Perfusion lung scans provide a guide to which patients with apparent primary pulmonary hypertension merit angiography.
1988
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Pulmonary Vascular Disease in Adults With Congenital Heart Disease
2007
Do Patients With Primary Pulmonary Hypertension Develop Extensive Central Thrombi?
1995
Blade Balloon Atrial Septostomy in Patients With Severe Primary Pulmonary Hypertension
1995
INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATES
1998
Pharmacologically induced Pulmonary Vasodilatation in Children and Young Adults with Primary Pulmonary Hypertension
1986
Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure
1987
Pulmonary Arterial Hypertension
2006
The controlled delivery of drugs to the lung
1995
Primary Pulmonary Hypertension as a Risk Factor for the Development of Obliterative Bronchiolitis in Lung Allograft Recipients
1996
British Guideline on the Management of Asthma
2008
Cyclodextrin Drug Carrier Systems
1998 Standout
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
2002 Standout
Clinical Correlates and Reference Intervals for Pulmonary Artery Systolic Pressure Among Echocardiographically Normal Subjects
2001
Severe Left Ventricular Dysfunction Secondary to Primary Pulmonary Hypertension: Bridging Therapy With Bosentan Before Lung Transplantation
2005
Vasodilator Therapy for Primary Pulmonary Hypertension in Children
1999
Hemodynamic Effects of Bosentan, an Endothelin Receptor Antagonist, in Patients With Pulmonary Hypertension
2000
A Randomized Trial Comparing Lung-Volume–Reduction Surgery with Medical Therapy for Severe Emphysema
2003 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.
1989
Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension
2004
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease
2016
Comparison of bronchopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension.
1997
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Survival in Primary Pulmonary Hypertension
2002
Interleukin-13: Central Mediator of Allergic Asthma
1998 StandoutScience
Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension
2008
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
2000
Primary Pulmonary Hypertension and Pregnancy
1986
Effects of Sleep Deprivation on Neural Circulatory Control
2000
Primary Pulmonary Hypertension
1993
Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial
2000
THROMBOPHLEBITIS AND PULMONARY EMBOLISM IN THE ELDERLY PATIENT
1993
Primary Pulmonary Hypertension
1987
Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension
2008
Primary Pulmonary Hypertension
1987 Standout
Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension
2003
Assessment of Survival in Patients With Primary Pulmonary Hypertension
2002
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
2003
Works of Gilbert E. D’Alonzo being referenced
Comparison of Oxygen Therapy With Nasal Continuous Positive Airway Pressure on Cheyne-Stokes Respiration During Sleep in Congestive Heart Failure
1999
Day-Night Patterns in Bronchial Patency and Dyspnea: Basis for Once-Daily and Unequally Divided Twice-Daily Theophylline Dosing Schedules
1987
Vasodilators and Primary Pulmonary Hypertension
1989
Effects of Nasal Continuous Positive Airway Pressure on Oxygen Body Stores in Patients With Cheyne-Stokes Respiration and Congestive Heart Failure
2003
An Assessment of PeaK Expiratory Flow as a Surrogate Measurement of FEV1 in Stable Asthmatic Children
1989
Lung Volume Reduction Surgery in Ventilator-Dependent COPD Patients
1996
Survival in Patients with Primary Pulmonary Hypertension
1991 Standout
Asthma deaths during sports
2004
Measurements of morning and evening airflow grossly underestimate the circadian variability of FEV1 and peak expiratory flow rate in asthma.
1995
Sleep in the Intensive Care Unit
1995
The Mechanisms of Abnormal Gas Exchange in Acute Massive Pulmonary Embolism 1, 2
1983
Salmeterol Xinafoate as Maintenance Therapy Compared With Albuterol in Patients With Asthma
1994
Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension
1985
clinical investigations
1984
Biological rhythms and medicine
1984
Comparison of Progressive Exercise Performance of Normal Subjects and Patients with Primary Pulmonary Hypertension
1987